Detalles de la búsqueda
1.
Ruxolitinib in severe COVID-19: Results of a multicenter, prospective, single arm, open-label clinical study to investigate the efficacy and safety of ruxolitinib in patients with COVID-19 and severe acute respiratory syndrome
Rev Fac Cien Med Univ Nac Cordoba
; 78(3): 294-302, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617700
Resultados
1 -
1
de 1
1
Próxima >
>>